Compare Muromachi Chemicals, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 14.97%
2
The company is Net-Debt Free
3
Healthy long term growth as Net Sales has grown by an annual rate of 86.71% and Operating profit at 48.25%
4
With a growth in Net Sales of 5.12%, the company declared Very Positive results in Nov 25
5
With ROCE of 19.66%, it has a very attractive valuation with a 1.63 Enterprise value to Capital Employed
6
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 4,001 Million (Micro Cap)
10.00
NA
0.00%
0.22
14.67%
1.44
Revenue and Profits:
Net Sales:
1,970 Million
(Quarterly Results - Feb 2026)
Net Profit:
94 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.97%
0%
9.97%
6 Months
20.0%
0%
20.0%
1 Year
40.76%
0%
40.76%
2 Years
14.29%
0%
14.29%
3 Years
18.23%
0%
18.23%
4 Years
-25.98%
0%
-25.98%
5 Years
0%
0%
0.0%
Muromachi Chemicals, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
86.71%
EBIT Growth (5y)
48.25%
EBIT to Interest (avg)
19.40
Debt to EBITDA (avg)
1.19
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
1.56
Tax Ratio
31.07%
Dividend Payout Ratio
41.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.97%
ROE (avg)
16.53%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.75
EV to EBIT
8.27
EV to EBITDA
6.45
EV to Capital Employed
1.62
EV to Sales
0.70
PEG Ratio
0.38
Dividend Yield
NA
ROCE (Latest)
19.66%
ROE (Latest)
16.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Feb'26 - YoY
Feb'26
Feb'25
Change(%)
Net Sales
1,969.80
1,873.90
5.12%
Operating Profit (PBDIT) excl Other Income
244.60
229.40
6.63%
Interest
12.50
6.90
81.16%
Exceptional Items
0.00
0.00
Consolidate Net Profit
93.70
128.20
-26.91%
Operating Profit Margin (Excl OI)
100.00%
100.80%
-0.08%
USD in Million.
Net Sales
YoY Growth in quarter ended Feb 2026 is 5.12% vs 21.47% in Feb 2025
Consolidated Net Profit
YoY Growth in quarter ended Feb 2026 is -26.91% vs 31.76% in Feb 2025
Annual Results Snapshot (Consolidated) - May'25
May'25
May'24
Change(%)
Net Sales
6,653.00
6,369.10
4.46%
Operating Profit (PBDIT) excl Other Income
593.90
558.00
6.43%
Interest
29.00
18.50
56.76%
Exceptional Items
-77.40
47.60
-262.61%
Consolidate Net Profit
241.30
330.20
-26.92%
Operating Profit Margin (Excl OI)
65.00%
66.20%
-0.12%
USD in Million.
Net Sales
YoY Growth in year ended May 2025 is 4.46% vs 1.24% in May 2024
Consolidated Net Profit
YoY Growth in year ended May 2025 is -26.92% vs 28.83% in May 2024
About Muromachi Chemicals, Inc. 
Muromachi Chemicals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






